Semantics, inflammation, cytokines and common sense

Cytokine and Growth Factor Reviews

Volumn 9, Issue 3-4, 1998, Pages 191-196

  Kushner, Irving ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Cytokines; Homeostasis; Inflammation; Inflammatory; Stress

Indexed keywords

CYTOKINE;

ANIMAL; HEMOSTASIS; HUMAN; IMMUNOLOGY; INFLAMMATION; LANGUAGE; NOMENCLATURE; NONHUMAN; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW; SEMANTICS;

EID: 0344507500     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(98)00016-1     Document Type: Review

References (63)

1. Dorland's Illustrated Medical Dictionary. 28 ed. 1994, Philadelphia: Saunders.
2. Noble PW, Henson PM, Lucas C, Mora-Worms M, Carr PC, Riches DWH. Transforming growth factor-β primes macrophages to express inflammatory gene products in response to particulate stimuli by an autocrine/paracrine mechanism. J Immunol 1993, 151, 979-989.
3. Kobzik L, Huang S, Paulauskis JD, Godleski JJ. Particle opsonization and lung macrophage cytokine response. J Immunol 1993, 151, 2753-2759.
4. Barab F, Gilbert C, Liao N, Bourgoin SG, Naccache PH. Crystal-induced neutrophil activation VI. Involvement of FcgTIIIB (CD16) and CD11b in response to inflammatory microcrystals. FASEB J 1998, 12, 209-220.
5. Chapman PT, Yarwood H, Harrison AA, Stocker CJ, Jamar F, Gunde RH, Peters AM, Haskard DO. Endothelial activation in monosodium urate monohydrate crystal-induced inflammation - In vitro and in vivo studies on the roles of tumor necrosis factor alpha and interleukin-1. Arthritis and Rheumatism 1997, 40, 955-965.
6. Hunter J. A Treatise on the Blood, Inflammation, and Gun-Shot Wounds. Bradford T, ed. Philadelphia, 1796.
7. Gallin JI, Goldstein IM, Snyderman R, eds. Inflammation: Basic Principles and Clinical Correlates. Raven Press, 1992.
8. Carleton RA. Dichotomous disservice? Ann Intern Med 1997, 126, 589-591.
9. Sporn MB. The importance of context in cytokine action. Kidney Int 1997, 51, 1352-1354.
10. Licinio J. Central nervous system cytokines and their relevance for neurotoxicity and apoptosis. J Neural Trans 1997, 49, 169-175.
11. Roeder I, de Haan G, Engel C, NijhofW, Dontje B, Loeffler M. Interactions of erythropoietin, granulocyte colony-stimulating factor, stem cell factor, and interleukin-11 on murine hematopoiesis during simultaneous administration. Blood 1998, 91, 3222-3229.
12. Wahl SM, McCartney-Francis N, Mergenhagen SE. Inflammatory and immunomodulatory roles of TGFaβ. Immunol Today 1989, 10, 258-261.
13. Wahl SM, Costa GL, Mizel DE, Allen JB, Skaleric U, Mangan DF. Role of transforming growth factor beta in the pathophysiology of chronic inflammation. J Peridontol 1993, 64, 450-455.
14. Essner R, Rhoades K, McBride DL, Morton DL, Economou JS. IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. J Immunol 1989, 142, 3857-3861.
15. Orino E, Sone S, Nii A, Ogura T. IL-4 upregulates IL-1 receptor antagonist gene expression and its production in human blood monocytes. J Immunol 1992, 149, 925-931.
16. Colotta F, Sironi M, Borre A, Luini W, Maddalena F, Mantovani A. Interleukin 4 amplifies monocyte chemotactic protein and interleukin 6 production by endothelial cells. Cytokine 1992, 4, 24-28.
17. Muller KM, Juanin F, Masouye I, Saurat JH, Hauser C. TH2 cells mediate IL-4-dependent local tissue inflammation. J Immunol 1993, 150, 5576-5584.
18. Lukacs NW, Addison CL, Gauldie J, Graham F, Simpson K, Stricter RM, Warmington K, Chensue SW, Kunkel SL. Transgene-induced production of IL-4 alters the development and collagen expression of T helper cell 1-type pulmonary granulomas. J Immunol 1997, 158, 4478-4484.
19. Ying S, Meng Q, Barata LT, Robinson DS, Durham SR, Kay AB. Associations between IL-13 and IL-4 (mRNA and protein), vascular cell adhesion molecule-1 expression, and the infiltration of eosinophils, macrophages, and T cells in allergen-induced late-phase cutaneous reactions in atopic subjects. J Immunol 1997, 158, 5050-5057.
20. Orlando S, Matteucci C, Fadlon EJ, Buurman WA, Bardella MT, Colotta F, Introna M, Mantovani A. TNF-alpha, unlike other pro- and anti-inflammatory cytokines, induced rapid release of the IL-1 type II decoy receptor in human myelomonocytic cells. J Immunol 1997, 158, 3861-3868.
21. Tilg H, Peschel C. Interferon-alpha and its effects on the cytokine cascade: a pro- and anti-inflammatory cytokine. Leukemia and Lymphoma 1996, 23, 55-60.
22. Weissmann G. Prostaglandins as modulators rather than mediators of inflammation. J Lipid Mediators 1993, 6, 275-286.
23. Clancy RM, Abramson SB. Nitric oxide: a novel mediator of inflammation. Proceedings of the Society for Experimental Biology and Medicine 1995, 210, 101.
24. Jenkins JK, Arend WP. Interleukin 1 receptor antagonist production in human monocytes is induced by IL-1 alpha, IL-3, IL-4 and GM-CSF. Cytokine 1993, 5, 407-415.
25. Tilg H, Dinarello CA. Interleukin-6 and acute phase proteins: anti-inflammatory and immunsuppressive mediators. Immunol Today 1997, 18, 428-432.
26. Kamradt R, Burmester GR. Cytokines and arthritis: is the Th1/Th2 paradigm useful for understanding pathogenesis? J Rheumatol 1998, 25, 6-8.
27. Joosten LA, Lubberts E, Helsen MM, van den Berg WB. Dual role of IL-12 in early and late stages of murine collagen type II arthritis. J Immunol 1997, 159, 4094-4102.
28. Boissier MC, Chiocchia G, Bessis N, Hajnal J, Garotta G, Nicoletti F, Fournier C. Biphasic effect of interferon-gamma in murine collagen-induced arthritis. European J Immunol 1995, 25, 1184-1190.
29. Mulligan MSW, Warner RL, Foreback JL, Shanley TP, Ward PA. Protective effects of IL-4, IL-10, IL-12, and IL-13 in IgG immune complex-induced lung injury. J Immunol 1997, 159, 3483-3489.
30. Hubner G, Brauchle M, Smola H, Madlener M, Fassler R, Werner S. Differential regulation of pro-inflammatory cytokines during wound healing in normal and glucocorticoid-treated mice. Cytokine 1996, 8, 548-556.
31. Gabay C, Smith M, Jr, Eidlen D, Arend WP. Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein. J Clin Invest 1997, 99, 2930-2940.
32. Tanuma N, Kojima T, Shin T, Aikawa Y, Kohji T, Ishihara Y, Matsumoto Y. Competitive PCR quantification of pro-and anti-inflammatory cytokine mRNA in the central nervous system during autoimmune encephalomyelitis. J Neuroimmunol 1997, 73, 197-206.
33. Fattori E, Cappelletti M, Costa P, Sellitto C, Cantoni L, Carelli M, Faggioni R, Fantuzzi G, Ghezzi P, Poli V. Defective inflammatory response in interleukin 6-deficient mice. J Exp Med 1994, 180, 1243-1250.
34. Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T, Zinkernagel R, Bluethmann H, Kohler G. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 1994, 368, 339-342.
35. Paulus HE. Concepts and targets for drug treatment of chronic rheumatic diseases, In Paulus HE, Furst DE, Dromgoole SH, eds. Drugs For Rheumatic Disease. Churchill Livingstone: New York, 1987.
36. Bunim JJ, Ziff M, McEwen C. Evaluation of prolonged cortisone therapy in rheumatoid arthritis. Am J Med 1955, 18, 27-40.
37. Bernard C. Lecons sur les phenomenes de la vie. 1878, Paris: Librairie J-B Bailliere et Fils.
38. Kushner I. The acute phase response: from Hippocrates to cytokine biology. Eur Cytokine Net 1991, 2, 75-80.
39. Gabay C, Kushner I. Acute phase proteins and other systemic responses to inflammation. N Eng J Med (in press).
40. Kushner I. The phenomenon of the acute phase response. Ann N York Acad Sci 1982, 389, 39-48.
41. McCarty M. Historical perspective on C-reactive protein. Ann N York Acad Sci 1982, 389, 1-10.
42. Dubos RJ. The Professor, The Institute and DNA. New York: The Rockefeller University Press, 1976.
43. Committee. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20, 864-874.
44. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Eng J Med 1995, 332, 1351-1362.
45. Seyle H. Stress. 1950, Montreal, Canada: Acta Medical Publisher.
46. Chrousos GP, Gold PW. The concepts of stress system disorders: overview of behavioral and physical homeostasis. JAMA 1992, 267, 1244-1252.
47. Sternberg EM. Emotions and disease: From balance of humors to balance of molecules. Nature Med 1997, 3, 264-267.
48. Joyce PR, Hawes CR, Mulder RT, Sellman JD, Wilson DA, Boswell DR. Elevated levels of acute phase plasma proteins in major depression. Biol Psych 1992, 32, 1035-1041.
49. LeMay LG, Vander AJ, Kluger MJ. The effects of psychological stress on plasma interleukin-6 activity in rats. Physiol and Behav 1990, 47, 957-961.
50. Maes M, Delange J, Ranjan R, Meltzer HY, Desnyder R, Cooremans W, Scharpe S. Acute phase proteins in schizophrenia, mania and major depression: Modulation by psychotropic drugs. Psych Res 1997, 66, 1-11.
51. Sporn MB, Roberts AB. Peptide growth factors are multifunctional. Nature 1988, 332, 217-219.
52. Van Wyk JJ. Remembrances of our founders: will growth factors, oncogenes, cytokines and gastrointestinal hormones return us to our beginnings? Endocrinol 1992, 130, 3-5.
53. Senturk LM, Arici A. Leukemia inhibitory factor in human reproduction. American J Repro Immunol 1998, 39, 144-151.
54. Mundy GR. Role of cytokines in bone resorption. J Cell Biochem 1993, 53, 296-300.
55. Poli V, Balena R, Fattori E, Markatos A, Yamamoto M, Tanaka H, Ciliberto G, Rodan GA, Costantini F. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J 1994, 13, 1189-1196.
56. Sharkey A. Cytokines and implantation. Rev Repro 1998, 3, 52-61.
57. Deutschman CS, DeMaio A, Clemens MG. Sepsis-induced attenuation of glucagon and 8-BrcAMP modulation of the phosphoenolpyruvate carboxykinase gene. Am J Physio 1995, 269, R584-R591.
58. Grunfeld C, Soued M, Adi S, Moser AH, Fiers W, Dinarello CA, Feingold KR. Interleukin 4 inhibits stimulation of hepatic lipogenesis by tumor necrosis factor, interleukin 1, and interleukin 6 but not by interferon-α1. Cancer Res 1991, 51, 2803-2807.
59. Li Y. Stashenko P. Proinflammatory cytokines tumor necrosis factor-α and IL-6, but not IL-1, down-regulate the osteocalcin gene promotor. J Immunol 1992, 148, 788-794.
60. Jarskog LF, Xiao H, Wilkie MB, Lauder JM, Gilmore JH. Cytokine regulation of embryonic rat dopamine and serotonin neuronal survival in vitro. Int J Dev Neurosci 1997, 15, 711-716.
61. Mehler MF, Kessler JA. Cytokines and neuronal differentiation. Cri Rev Neurobiol 1995, 9, 419-446.
62. Sawada M, Suzumura A, Marunouchi T. Cytokine network in the central nervous system and its roles in growth and differentiation of glial and neuronal cells. Int J Dev Neurosci 1995, 13, 253-264.
63. Tickle C. Worlds in common through NF-kB. Nature 1998, 392, 547-549.